论文部分内容阅读
肝脏是结直肠癌血行转移最主要的靶器官,结直肠癌肝转移是结直肠癌治疗的重点和难点之一。约有15.0%~25.0%结直肠癌患者在确诊时即合并有肝转移,而另15.0%~25.0%的患者将在结直肠癌原发灶根治术后发生肝转移,其中绝大多数(80.0%~90.0%)的肝转移灶无法获得根治性切除~([1])。结直肠癌肝转移是结直肠癌患者最主要的死亡原因,未经治
Liver is the most important target organ of colorectal cancer hematogenous metastasis. Colorectal cancer liver metastasis is one of the key and difficult points of colorectal cancer treatment. About 15.0% ~ 25.0% of patients with colorectal cancer are diagnosed with liver metastasis, while the other 15.0% ~ 25.0% of patients with liver metastases after radical resection of colorectal cancer, the vast majority (80.0 % ~ 90.0%) of liver metastases can not get radical resection ~ ([1]). Colorectal cancer liver metastasis is the most important cause of death in patients with colorectal cancer, without treatment